| |
| |
|
| Insider
Information: |
Braunstein Scott |
| Relationship: |
Director |
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
357,793 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,029,147 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
357,793 |
|
|
| Total
Value |
$1,029,147 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Esperion Therapeutics, Inc. |
ESPR |
Director |
2019-05-29 |
5,019 |
|
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
SVP, Strategy & Corp. ... |
2017-06-14 |
20,982 |
2016-01-29 |
0 |
Premium* |
|
|
Marinus Pharmaceuticals Inc |
MRNS |
|
2024-03-27 |
273,512 |
2019-12-13 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2019-12-31 |
31,780 |
2019-12-31 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2020-01-10 |
26,500 |
2020-01-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRNS |
Marinus Pharmaceuticals I... |
CHAIRMAN AND CEO |
• • – |
2024-03-27 |
4 |
OE |
$4.28 |
$214,000 |
D/D |
50,000 |
273,512 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
CHAIRMAN AND CEO |
• • – |
2024-02-16 |
4 |
AS |
$9.94 |
$117,789 |
D/D |
(11,850) |
223,512 |
0 |
% |
|
| MRNS |
Marinus Pharmaceuticals I... |
CHAIRMAN AND CEO |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
74,600 |
235,362 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
CHAIRMAN AND CEO |
• • – |
2023-08-08 |
4 |
AS |
$8.94 |
$268 |
D/D |
(30) |
160,762 |
0 |
% |
|
| MRNS |
Marinus Pharmaceuticals I... |
CHAIRMAN AND CEO |
• • – |
2023-08-07 |
4 |
AS |
$9.55 |
$61,244 |
D/D |
(6,413) |
160,792 |
0 |
% |
|
| MRNS |
Marinus Pharmaceuticals I... |
CHAIRMAN AND CEO |
• • – |
2023-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
167,205 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Chairman and CEO |
• • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,305 |
87,205 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
42,900 |
67,900 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
Director |
– • – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
26,500 |
26,500 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
31,780 |
31,780 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-12-13 |
4 |
B |
$1.25 |
$125,000 |
D/D |
100,000 |
100,000 |
2.81 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,967 |
5,019 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Strategy & Corp. Dev. |
• – – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
20,982 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Strategy & Corp. Dev. |
• – – |
2017-06-05 |
4 |
S |
$43.32 |
$33,271 |
D/D |
(768) |
9,982 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Strategy & Corp. Dev. |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
10,750 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
SVP, Strategy & Corp. Dev. |
• – – |
2016-01-29 |
4 |
B |
$58.92 |
$117,840 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2015-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
